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In the mid 1980s, a hypervirulent variant of Klebsiella
pneumoniae (hvKP) causing serious community-
acquired clinical syndromes with pyogenic liver
abscesses, possibly associated with bacteraemic extrahe-
patic disseminations, was identified in Taiwan. Gener-
ally, patients presenting with these syndromes were
young and without significant comorbidities, with the
exception of diabetes that was found to be a major risk
factor.1,2 After those first reports from the Far East, simi-
lar cases have been subsequently reported worldwide.3-5
The hvKP strains differ from classical K. pneumoniae
strains for an increased virulence potential, that can be
evaluated in animal models of infection (usually mouse
or Galleria mellonella).6 The increased virulence poten-
tial has been associated with the expression of several
traits, present in variable combinations, including: i)
iron-scavenging systems (e.g. the IucA aerobactin, the
EntH enterobactin, the IroB salmochelin and the Irp2
yersiniabactin);7 ii) the allantoin metabolism pathway;8
iii) the Kpc fimbriae;9 and iv) certain capsular types (e. g.
K1 and K2) produced in increased abundance to form a
so-called “hypercapsule.”10 Due to production of the
hypercapsule, the colonies of these strains typically
exhibit the hypermucoviscous (HM) phenotype, denoted
by an abundant production of capsular material and a
positive “string test.”4 The HM phenotype has been
related with the acquisition of plasmid-borne rmpA and
rmpA2 genes, encoding transcriptional regulators that
activate capsular biosynthesis,11,12 or with mutations of
the chromosomal rcsA and rcsB genes, encoding a signal-
ing system involved in the regulation of capsular biosyn-
thesis.10,11 However, in some strains the mechanism(s)
underlying the HM phenotype remain elusive.13,14 The
HM phenotype apparently contributes to the virulence
of hvKP strains and is widely considered a surrogate
marker of increased virulence.15,16 However, the relation-
ship between hvKP and the HM phenotype, i. e. whether
all hvKP are HM and vice versa, remains unclear.4 Of the
hvKP strains thus far described, most belong to a single
clonal group (CG), namely CG23, although hvKP strains
of other lineages (e. g. of sequence type ST86) have occa-
sionally been reported. Consistently with their commu-
nity origin, the hvKP strains are usually susceptible to
antibiotics.4
Unlike the hvKP strains, classical K. pneumoniae
strains typically behave as opportunistic pathogens of
lower virulence potential,17-19 mostly causing infections
in hospitalized patients with some degree of impairment
of the host defenses.20 On the other hand, these strains
often carry multiple resistance determinants to antibiot-
ics which make treatment more difficult.20 Carbapenem-
resistant K. pneumoniae (CRKP), in particular, have
emerged as one of the ultimate challenges for public
health because of their extended antibiotic resistance
phenotypes and ability to rapidly disseminate in the hos-
pital setting and eventually even outside.21 The spread of
CRKP is mostly linked to the expansion of successful
high-risk clones producing carbapenemases of various
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types (e. g. KPC, NDM, OXA-48 or VIM), with a para-
digmatic example represented by the CG258 clonal line-
age harbouring blaKPC carbapenemase genes.
22-24
The current dichotomy between CRKP and hvKP
populations in terms of resistance and virulence, how-
ever, could eventually be blurred, and the emergence of
CRKP with an increased virulence potential is a worri-
some perspective.25 In fact, HM strains producing
extended-spectrum b-lactamases (ESBL) and carbapene-
mases have recently been reported,26-34 being a matter of
considerable concern.
In this work we describe a case of liver abscess fol-
lowed by fatal bacteremic infection in a liver transplant
patient, caused by a CRKP strain that showed an HM
phenotype (CRHMKP). We also reviewed the recent lit-
erature reporting cases of CRKP with an HM phenotype.
KP04C62 was isolated in August 2011 from the blood
cultures of a 52 years-old caucasic patient with septic
shock. The strain exhibited an HM phenotype and was
resistant to carbapenems (meropenem MIC, >64 mg/
ml), extended-spectrum cephalosporins, conventional
b-lactamase inhibitor combinations (amoxicillin-
clavulanate, piperacillin-tazobactam), amikacin, fluoro-
quinolones, trimethoprim-sulfamethoxazole, and colistin
(MIC, 32 mg/ml), while retaining susceptibility to genta-
micin (MIC, 1 mg/ml) and tigecycline (MIC, 1 mg/ml).
The patient was diabetic and had been subjected to liver
transplantation for end-stage liver disease 6 months
before. Immunosuppression had been with cyclosporine,
methylprednisolone and mycophenolate mofetil. Four
months after the transplantation a voluminous abscess
in the VI and VII liver segments was diagnosed, and a
CRHMKP with the same resistance profile as KP04C62
was isolated from a drainage. Despite drainage, hyper-
baric oxygen treatment and combination antibiotic ther-
apy with meropenem, gentamicin, and colistin, the
abscess persisted. The patient was then subjected to sur-
gical resection of the V, VI, VII and VIII liver segments,
and the antimicrobial therapy was modified (substitution
of meropenem with tigecycline). However, the clinical
condition of patient worsened and he died of peritonitis
and septic shock few days after surgery.
A PubMed search (accessed on December 27th 2016),
using as search terms “Klebsiella,” “hypermucoviscous,”
and “resistance” revealed a total of 8 reports describing
cases of human infections or colonizations caused by
CRHMKP strains. These reports, summarized in Table 1,
are briefly reviewed below.
Zhang et al. (2015), in a multi-center retrospective
study which analyzed the clinical and laboratory features
of 28 cases of CRKP infections from 9 cities in China,
observed between 2012 and 2013, detected 5 HM strains
(17.8%) of which only 3 were positive for rpmA/rpmA2
genes. The CRHMKP strains caused 2 cases of pneumo-
nia and 3 of bloodstream infection. All patients for
whom information were available (4 out of 5) survived
the infection. The infected patients, aged from one day
to 84 years, suffered of multiple underlying diseases and
were all hospitalized. Three out of the 5 strains belonged
to ST11 and were non-typeable by conventional serotyp-
ing methods. Another non-typeable strain was assigned
to ST1700, while the remaining strain was an ST65 of
serotype K2. Interestingly, the latter strain, isolated from
a one-day-old infant who developed septicaemia during
treatment of bronchopulmonary dysplasia and survived
the infection, showed a remarkable in vitro resistance to
serum killing and a high virulence in a mouse peritonitis
infection model. By contrast, the other 4 strains were
avirulent in the same murine model. The ST65K2 strain
carried the aerobactin and the enterobactin siderophores,
and was resistant to carbapenems due to decreased
expression of OmpK35 and OmpK36 associated with
SHV-11 and TEM-53 b-lactamases production.30
Andrade et al. (2014) reported on a CRHMKP strain
obtained from the blood cultures of a 36 years-old
patient, during a hospital outbreak of ST11 K. pneumo-
niae producing KPC-2 occurred in 2013 in a tertiary-
care university hospital in Ribeir~ao Preto (Brazil).27 The
patient, admitted for acute myeloid leukemia, died for
septic shock after a few days. The strain showed a multi-
drug resistant phenotype including colistin resistance.
Capsular serotyping was not performed. The rmpA/
rmpA2 genes were not detected and the mechanism
underlying the HM phenotype remained unknown.
Wei et al. (2015) reported on a CRHMKP strain
obtained in January 2014 from a 47 years-old patient
with multiple traumatic injuries due to a traffic accident
admitted in the Intensive Care Unit of a university teach-
ing hospital in NanChang (China). The strain was iso-
lated 20 d after hospital admission from blood, a chronic
wound, and a decubitus ulcer, and the patient eventually
died of infection. The strain belonged to ST11, carried
the blaKPC-2 gene, expressed a K1 capsular serotype, and
was positive for the rmpA/rmpA2 genes.32
Yao et al. (2015) performed a retrospective surveil-
lance study aimed to identify HM strains in a collection
of CRKP (selection criteria were positive string test and
imipenem and/or meropenem minimum inhibitory con-
centration ! 4mg/L) from a large Chinese hospital in the
period January 2010-August 2014. Among the 60 CRKP
isolated during the study period from 33 patients, 7 (iso-
lated since February 2013 from 4 patients) were positive
for the HM phenotype. These CRHMKP strains were
responsible for 2 cases of pneumonia, one bloodstream
infection secondary to urinary tract infection, and one
gut colonization. All cases were hospital-acquired and
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Table 1. Summary of articles available at PubMed database, accessed on December 27th 2016, describing cases of infections or colonization caused by CRHMKP. Legend: pattern 1, strains with K1, positive for rmpA/rmpA2 genes, mostly of ST23 but also of other sequence types; pattern 2, strains with
non-typeable serotype, mostly negative for rmpA/rmpA2); !, deduced from wzi gene sequence; -, data not available.
Isolate
identifcative Country Year ST K type
Carbapenems resistance
mechanism
rmpA
and/or
rmpA2 Pattern
Polymixins
susceptibility
Tigecycline
susceptibility animal model clinical sample disease
age
(years) sex comorbidities therapy outcome
Reference
n.
Strain 1 China 2013 11 non-typable OmpK35/36 decreased
expression associated
with b-lactamases
production
negative 2 – susceptible avirulent in murine
peritonitis
sputum pneumonia 84 famale Coronary heart disease,
Diabetes mellitus,
Hypertension,
Cerebral infarction
Moxifloxacin,
Meropenem,
survived 30
Strain 2 China 2013 1700 non-typable KPC-2, IMP-4 negative 2 – resistant avirulent in murine
peritonitis
abdominal fluid abdominal
infection,
septic shock
14 famale Acute myocarditis, Acute
renal insufficiency
Piperacillin/
tazobactam,
Meropenem,
Imipenem
unknown 30
Strain 3 China 2013 65 K2 OmpK35/36 decreased
expression associated
with b-lactamases
production
positive – – susceptible highly virulent in
murine
peritonitis
blood septicemia 1 day male Premature,
Bronchopulmonary
dysplasia, Hyaline
membrane disease,
Severe asphyxia,
Brain damage,
Hypoglycemia
Ceftazidime,
Piperacillin/
tazobactam,
Imipenem,
Ceftazidime/
tazobactam,
Meropenem
survived 30
Strain 4 China 2012 11 non-typable KPC-2 positive 2 – susceptible avirulent in murine
peritonitis
abdominal fluid pneumonia 71 male Cholecystectomy, Bile
duct obstruction,
Coronary heart
disease, cancer, acute
respiratory failure
Levofloxacin,
Cefoperazone/
sulbactam,
Piperacillin/
tazobactam
survived 30
Strain 5 China 2012 11 non-typable KPC-2 positive 2 – susceptible avirulent in murine
peritonitis
bile biliary tract
infection,
pulmonary
infection,
sepsis
76 male Cholecystectomy,
common bile duct
stent, Chronic
bronchitis, Calculus of
intrahepatic duct,
Respiratory failure
Meropenem,
Imipenem,
Cefepime,
Fosfomycin,
Amoxicillin/
clavulanic acid,
Tigecycline
survived 30
RP59 Brazil 2013 11 – KPC-2 negative 2 resistant susceptible – blood bacteraemia 36 male Acute myeloid leukemia unknown died 27
KP70–2 China 2013 23 K1 KPC-2 positive 1 susceptible susceptible – sputum and
blood
samples
septic shock 50 male brain injury cefoperazone-
sulbactam
died 31
KP1088–2 China 2013 23 K1 KPC-2 positive 1 susceptible susceptible – sputum and
blood
samples
septic shock 67 male multiple injury unknown died 31
KP86 China 2013 1797 K1 KPC-2 positive 1 susceptible susceptible – sputum and
blood
samples
septic shock 88 male Abdominal infection unknown died 31
KP91 China 2013 1797 K1 KPC-2 positive 1 susceptible susceptible – sputum and
blood
samples
septic shock 73 famale Septic arthritis unknown died 31
KP96 China 2013 1797 K1 KPC-2 positive 1 susceptible susceptible – sputum and
blood
samples
septic shock 32 male none unknown died 31
3089 Argentina 2013 23 K1 KPC-2 positive 1 susceptible susceptible – tracheal
secretion
suspected
pneumonia
85 male acute myeloid leukemia unknown died 28
Kp1500 China 2014 11 K1 KPC-2 positive 1 – susceptible highly virulent in
murine
peritonitis
blood, wound
and
decubitus
ulcer
bacteraemia 47 famale multiple traumatic
injuries
unknown died 32
(Continued on next page )
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Table 1. (Continued )
Isolate
identifcative Country Year ST K type
Carbapenems resistance
mechanism
rmpA
and/or
rmpA2 Pattern
Polymixins
susceptibility
Tigecycline
susceptibility animal model clinical sample disease
age
(years) sex comorbidities therapy outcome
Reference
n.
cr-hvKP1, cr-
hvKP4
China 2013 65 K2 KPC-2 positive – – susceptible – urine, tracheal
secretion
colonization 78 male Respiratory failure,
Parkinson disease,
cerebrovascular
accident, duodenal
ulcer, hypertension,
chronic hepatitis,
paroxysmal atrial
fibrillation
none survived 29
cr-hvKP2, cr-
hvKP3 and cr-
hvKP5
China 2014 65 K2 KPC-2 positive – – susceptible – tracheal
secretion,
urine, blood
secondary
bacteraemia
after urinary
tract
infection
85 male Respiratory failure,
chronic obstructive
pulmonary disease,
hypertension,
secondary epilepsy,
cerebrovascular
accident
imipenem;
isepamicin
survived 29
cr-hvKP6 China 2014 25 K2 – positive – – susceptible – tracheal
secretion
pneumonia 68 male respiratory failure,
cerebrovascular
accident,
hypertension,
secondary epilepsy
cefoperazone–
sulbactam,
isepamicin
survived 29
cr-hvKP7 China 2014 11 non-typable KPC-2 negative 2 – resistant – tracheal
secretion
pneumonia 91 famale respiratory failure, chronic
obstructive
pulmonary disease,
colon carcinoma,
pleural effusion,
coronary artery
disease
ertapenem died 29
Klebsiella
pneumoniae
U25
India 2009–10 14 K2! OmpK36 mutation associated
with b-lactamases
production
negative – – – – urine – – – – – – 33
B20143 India 2014 11 K24! NDM-1 positive – – – – blood – – – – – – 34
B1647 India 2015 231 non-typable! OXA-232 negative 2 – – – blood – – – – – – 34
B20038 India 2015 43 K30! OXA-181 positive – – – – blood – – – – – – 34
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occurred in patients admitted for long periods, with sev-
eral co-morbidities. In 3 cases the K. pneumoniae strains
belonged to serotype K2 and carried the rmpA/rmpA2
genes (2 of ST65 and one of ST25). The remaining was
an ST11 strain of a non-typeable serotype, lacking the
rmpA/rmpA2 genes. All strains but one produced KPC-
2. One of the infected patients, a 91 years-old patient
affected by pneumonia caused by the ST11 strain, died
for heart failure while the other patients survived the
infection.29
Zhang et al. (2015) reported on 5 cases of infection by
CRHMKP with K1 capsular type, occurred in hospital-
ized patients in the Zhejiang Province of China in 2013.
All cases had a fatal outcome regardless of their original
health status. Genotyping results revealed that 2 strains
belonged to ST23 and the other 3 to a new genetically
related ST (ST1797, a double locus variant of ST23), and
that all strains carried the rmpA/rmpA2 genes and a plas-
mid-borne blaKPC-2 gene. In 2 cases the acquisition of
blaKPC-2 by a previously susceptible stain had occurred
after or during imipenem therapy.31 These are the first
described cases of acquisition of carbapenem-resistance
by clinical strains of a well known hypervirulent lineage.
Cejas et al. (2014) reported on a CRHMKP of ST23
and serotype K1, carrying the rmpA/rmpA2 genes and
producing the KPC-2 carbapenemase. The strain was
isolated in 2013 from the tracheal aspirate of an 85 year-
old man with a recent history of acute myeloid leukemia,
admitted to an intensive care unit in Buenos Aires,
Argentina. The patient, who was undergoing chemother-
apy with methotrexate and prednisone, died 3 weeks
after the isolation of the K. pneumoniae strain due to
causes that were not specified.28
Most recently, 2 articles announcing the genome
sequencing projects of 4 CRHMKP isolated in India,
from 3 bloodstream infections and one urinary tract
infection, have been published.33,34 The strains were of
different sequence types and capsular types, and carried
different carbapenem-resistance mechanisms. Only 2 of
them were positive for rmpA/rmpA2.
Altogether, according to our search, 21 CRHMKP
strains have been described in the literature. In most
cases the CRHMKP strains were from infections (only in
one case from colonization). The cases were mostly from
China (71.4%), but also from South America and India,
and occurred in patients previously hospitalized for
other causes. The most frequent site of isolation was
bloodstream (12 cases), followed by the respiratory tract
(often in concomitance with other sites; 11 cases). One
third of these strains belonged to ST23 or to genetically
related STs (ST25 and ST1797), one third to ST11, and
the remaining ones to several unrelated sequence types
(ST14, ST43, ST65, ST231 and ST1700). K1 and K2 were
the most common capsular types (12 of 21), with K1
being almost exclusively associated with ST23 or geneti-
cally related STs, while K2 with ST65, ST25 and ST14.
Several strains, mostly of ST11, were reported as non-
typable with conventional serotyping methods. Overall,
6 of 21 strains (28.6%) were negative for the presence of
rmpA/rmpA2 genes, revealing the existence of alternative
mechanisms underlying the HM phenotype. In most
CRHMKP strains resistance to carbapenems was imput-
able to the production of the KPC-2 carbapenemase (in
one case co-produced with IMP-4), but other carbapene-
mases (NDM-1 and OXA-48-like) were sporadically
reported. In 3 strains carbapenem resistance was due to
alterations in the major K. pneumoniae porins, OmpK35
and/or OmpK36, coupled with ESBL production.
Regarding the phenotype toward other antimicrobial
agents, CRHMKP strains retained, with few exceptions,
susceptibility to colistin and tigecycline (Table 1).
The 17 cases for which clinical data are available
occurred in patients of various ages (from 1 day to 91
years), with a predominance of males (70.5%) and a
cumulative in-hospital mortality rate for infected
patients of 56.2% (Table 1).
In summary, most CRHMKP strains described in the
literature could be gathered into 2 groups with distinctive
features: pattern 1, consisting of strains with K1 serotype,
positive for the rmpA/rmpA2 genes, mostly of ST23 or
genetically related STs; and pattern 2, consisting of
strains with a non-typable serotype, mostly of ST11 and
mostly negative for rmpA/rmpA2.
Interestingly, the mortality rate for patients infected
by strains with pattern 1 was significantly higher than
that observed for patients infected by strains with pattern
2 (100% vs. 40%; p value calculated by the Two tailed
Fisher’s exact test D 0.045). Furthermore, the 2 fatal
cases of infection by strains with pattern 2 were reported
in patients with underlying conditions that could have
significantly influenced the final outcome (age >90 y in
one case, and severe hematologic malignancy in the
other).
To investigate the genetic features of the KP04C62
strain, the genome was sequenced using the MiSeq plat-
form (Illumina Inc., San Diego, CA) and a 2 £ 300 bp
paired-end approach. In total 946,759 reads were obtained,
yielding an estimated average coverage of 103£, consider-
ing a genome size of 5.5 Mbp. Reads were assembled, using
the SPAdes software,35 into 147 contigs (N50 contig size,
268,882 bp). Scaffolds, annotated using the RAST soft-
ware,36 contained 5,598 coding sequences. The Whole
Genome Shotgun project has been deposited at DDBJ/
ENA/GenBank under the accession MIFX00000000. The
version described in this article is version MIFX01000000.
The genomic analysis showed that KP04C62 belonged to
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ST512 (a single-locus variant of ST258), and that it was
closely related to another ST512 strain isolated in another
Italian hospital in the same period (KPB-1, accession num-
ber AYOV00000000), which did not exhibit an HM phe-
notype.37 The 2 strains shared a common conserved
genome of approximately 5.4 Mbp using the Panseq
software,38 with only 50 SNPs (CSI phylogeny, https://cge.
cbs.dtu.dk/services/CSIPhylogeny/) in the core genome.
The content of acquired resistance genes of KP04C62
was consistent with the antibiotic resistance profile
(Table 2). As described previously, colistin resistance in
KP04C62 was attributed to the insertional inactivation of
the mgrB gene by an IS5-like element at nt 126.39
The KP04C62 virulence genes content was investigated
with a database of known K. pneumoniae virulence factors
created ad hoc, expanding the already existing database
available at http://bigsdb.pasteur.fr/klebsiella/klebsiella.html
(Table S1). Interestingly, KP04C62 harboured none of
the 76 putatively acquired virulence genes present in the
database. Concerning the housekeeping virulence genes,
we found a nonsense mutation in the regulatory fimK
gene, resulting in a truncated FimK protein at position
440. The loss of FimK function in the K. pneumoniae
TOP52 strain was previously reported to cause a higher
expression of type 1 pili, with enhanced ability to form
type 1-dependent biofilm and augmented virulence in a
murine urinary tract infection model.40 An analogous
profile of virulence genes, including the nonsense muta-
tion in the fimK gene, was found in the closely related
KPB-1 strain, which did not exhibit an HM phenotype.
Notably, the rmpA and rmpA2 genes were not
detected in KP04C62, while the rcsABCD genes of this
strain were identical to those found in the non-HM
KPB-1 strain. Compared to the latter strain, which has a
capsular gene cluster typical of clade II strains of the
CG258 lineage (cpsBO-4 type with wzi154 allele),
41 the
sequence of the capsular gene cluster of KP04C62 exhib-
ited 2 original differences: a missense T!C mutation at
position 221 of the wzc gene, resulting in a Leu!Pro
substitution at position 74 of the Wzc protein, and a
T!C missense mutation at position 332 of a putative
glycosyltransferase-encoding gene (Region 11007–11768
of AYOV01000044), resulting in a Cys!Ser substitution
at position 110 of the corresponding protein. Wzc is a
BY-kinase involved in the biosynthesis and transport of
exopolysaccharides, which interacts with Wza (a trans-
membrane protein) for the translocation of the capsular
polysaccharide from the periplasm across the outer
membrane.42 The amino acid substitution identified in
the Wzc of KP04C62 is situated in the N-terminal peri-
plasmic domain which carries the site of interaction with
Wza. The role of these original mutations in expression
of the HM phenotype of KP04C62 will be the subject of
future investigation.
To investigate the virulence potential of KP04C62 in
comparison with a known highly virulent, hvKP, strain
(NTUH-K2044, a typical hvKP ST23 strain with the K1
capsular serotype),43 we used a Galleria mellonella ani-
mal model, according to a described previously proto-
col.6,17 In this model, KP04C62 showed a virulence
potential that was significantly lower than that of
NTUH-K2044 (LD50 at 72 hours, 6.1 § 0.05 vs. 4.9 §
0.24, P value <0.01; 3 independent replicates). This
behavior was overall similar to that previously reported
for another KPC-producing CG258 strain with a cpsBO-4
capsular type (KKBO-1),17 and revealed that KP04C62
did not behave as a typical hvKP strain, at least in this
model. To assess whether the difference in the LD50 val-
ues could be, at least in part, attributed to a different
growth pattern of the studied strains, we analyzed the
growth of KP04C62, KKBO-1 and NTUH-K2044 at dif-
ferent pH values (pH 7, 6.5 and 6, in LB broth buffered
with 1M HCl), considering that a lower pH (around 6.5)
is encountered in the animal model 44 Growth was per-
formed at 37"C for 24 h, in a volume of 5 ml, and was
followed by monitoring A600 and CFU counts. Results of
these experiments, performed in triplicate, did not reveal
significant differences of growth patterns among the
studies strains (data not shown).
Overall, the KP04C62 strain described in this work
shared several characteristics with CRHMKP of pattern
2 (capsular locus organization typical of clade II of
CG258 strains, i.e. cpsBO-4, non-typeable with conven-
tional serotyping methods; negative for rmpA/rmpA2).
This strain caused a fatal systemic infection, originating
from a liver abscess, similarly to classic ST23 hvKP
strains. However, in this case the infection occurred in a
severely immunocompromised patient.
In conclusion, we described the clinical, epidemiologi-
cal and genetic features of the first CRHMKP strain of
ST512, producing the KPC-3 carbapenemase. The strain
was isolated in 2011, i. e. before most other similar
strains described in the literature, and shared several
characteristics with other described previously
CRHMKP of pattern 2, which have a lower virulence
potential compared with other HM strains that we
Table 2. Acquired antimicrobial resistance genes detected in
KP04C62 with the associated resistance phenotype.
Resistance genes
Gene Associated phenotype
blaTEM-1,DblaOXA-9, blaSHV-11 b-lactams excluding carbapenems
blaKPC-3 b-lactams including carbapenems
aac(60)Ib-cr Aminoglycosides and quinolones
dfrA12, sul1 Trimethoprim, sulphonamides
6 F. ARENA ET AL.
identified as pattern 1 (more often belonging to ST23 or
genetically related STs, with a K1 capsular serotype and
an extensive set of virulence factors, including the rmpA/
rmpA2 genes). Indeed, the analysis of the existing litera-
ture suggested that pattern 2 strains are likely able to
cause serious fatal infections (including liver abscesses)
only in immunocompromised patients. This hypothesis
was corroborated by the fact that, in the Galleria
mellonella infection model, KP04C62 had a virulence
potential inferior to a known hvKP strain and similar to
that of another CG258 KPC-producing, cpsBO-4 strain,
previously associated with low virulence.17
In our opinion, therefore, a laboratory positivity for
the string test in a CRKP isolate should be interpreted as
an alert for the possibility of an hvKP behavior, but con-
firmation requires further investigation of the genetic
content of virulence determinants and possibly testing of
virulence behavior in a suitable animal model. Further
analysis will be necessary to characterize the mechanism
underlying the HM phenotype in pattern 2 strains that
generally lack rmpA/rmpA2 determinants.
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